“Delivering on the timely close of the acquisition and bringing momentum into Day 1 in this challenging environment underscores the deep capability and disciplined execution from both companies.”, “This milestone is another key step in Elanco’s journey. If COVID-19 has made anything clear – it’s that the world has never needed animals and the work farmers and veterinarians do more,” Simmons said. GREENFIELD, Ind.--(BUSINESS WIRE)-- Keep them in mind when you update your Social Security information. "We remain positive on XPeng's long-term share gain and improving profitability. Apple and Moody's are two well-known winning Warren Buffett stocks. Bionano’s Genome Mapping Platform Could Be a Game Changer, Says Analyst, BofA Raises XPeng Price Target, Sees More Upside Ahead For EV Stock, Semiconductor Stocks To Buy And Watch Ahead Of Q4 Earnings Season, Stock market news live updates: S&P 500 powers to a record closing high on the final day of 2020, ending the year with a 16% rise, How To Become A Millionaire By Investing $15 A Day, Wall Street calls for shift away from 60/40 balanced portfolio despite strong returns this year. Scale and capabilities of the combined company position Elanco for the long term as a leader in the attractive, durable animal health industry. The stock’s $11.36 average price target suggests a 14% and a change from the current share price of $9.93. Innovation: Elanco’s robust R&D pipeline is now bolstered with five expected launch equivalents from Bayer – bringing Elanco’s anticipated total to 25 by 2024 – with five of those expected to launch by the end of 2021. Article: Elanco and Bayer - Animal heath’s largest ever acquisition is a done deal 11 August 2020 Elanco has closed its purchase of Bayer Animal Health - a deal that is expected to propel the former to second in the industry rankings. This company is one of many in the mid-market business financing niche, offering debt solutions and capital access to smaller firms that may not be able to secure lending from the larger markets. - Elanco Animal Health has agreed to make changes to a US$7.6-billion deal to buy several health care products for animals from Bayer AG … Goldman Sachs acted as financial advisor to Elanco and Paul, Weiss, Rifkind, Wharton & Garrison LLP, Hengeler Mueller and Slaughter and May acted as legal counsel to Elanco. (August 3, 2020) – Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has closed the acquisition of Bayer Animal Health. Due to Bionano’s latest surge, the figure indicates a 5% downside from current levels. At the same time, research shows increased time at home has changed the long-term relationship between pets and their owners, as pets increasingly provide valuable emotional support. (See FDUS stock analysis on TipRanks)TPG RE Finance Trust (TRTX)Returning to the REIT sector, we look at TPG RE Finance Trust, the real estate financing arm of global asset firm TPG. (See TRTX stock analysis on TipRanks)To find good ideas for dividend stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. If you’re worried about the stock market correcting, or eventually heading into bear market territory, then you will want to consider the exchange-traded funds (ETF) covered below. GREENFIELD, Ind. That rating is based on 4 reviews, including 2 Buys and 2 Holds. The transaction also broadens Elanco’s pet parasiticide portfolio with topical treatments and collars, making the blockbuster Seresto collar Elanco’s top product globally. Learn more at www.elanco.com. View source version on businesswire.com: Meanwhile, the 15-year fixed-rate mortgage dropped two basis points to an average of 2.17%, representing a record low for that mortgage product. For further discussion of these and other risks and uncertainties, see Elanco’s most recent filings with the United States Securities and Exchange Commission. The third quarter earnings, however, came in at 19 cents per share, down from 54 cents in the year-ago quarter. That said, it is hard to keep up with the current speed of the share gains, and the $1.42 average price target, suggests downside of 32%. The Elanco-Bayer deal first was announced last August, when Greenfield, Indiana-based Elanco offered $5.3 billion in cash and $2.3 billion in shares to Bayer, a German pharmaceuticals and agricultural chemicals giant that had been shedding assets to pay debts and legal costs associated with its purchase of the seed group Monsanto. The transaction also adds new R&D capabilities, including innovative dosing and delivery technology platforms, and provides access rights to Bayer’s Crop Science R&D pipeline and de-prioritized clinical pharma assets. It is very important to do your own analysis before making any investment. (To watch Dodd’s track record, click here)Wall Street is somewhat more divided on FDUS shares, a circumstance reflected in the Moderate Buy analyst consensus rating. View source version on businesswire.com: https://www.businesswire.com/news/home/20200803005176/en/, Investor Contact:Tiffany Kanaga+1.302.897.0668kanaga_tiffany@elanco.com, Media Contact:Colleen Parr Dekker+1.317.989.7011colleen_parr_dekker@elanco.com. The repurchase is for preferred stock shares, and goes alongside the existing repurchase policy of common shares.Analyst Stephen Laws, in his coverage of NRZ for Raymond James, writes, “We expect strong origination volumes and attractive gain on sale margins to drive strong near-term results, and we continue to expect a dividend increase in 4Q [...] For 4Q20, we are increasing our core earnings estimate by $0.02 per share to $0.35 per share. Back in Q1, the company pared back the common share dividend to 5 cents, in a move to preserve capital during the corona crisis. Forward-looking statements are based on our current expectations and assumptions regarding our business and other future conditions. The 30-year fixed-rate mortgage averaged 2.67% for the week ending Dec. 31, up a basis point from the new record low of 2.66% set the week prior, Freddie Mac (FMCC)reported Thursday. The transaction was valued at $6.89 billion. "Click here to check out Benzinga's EV Hub for the latest electric vehicle news.Benzinga's Take: There are plenty of reasons for investors to be excited about XPeng's future, but the stock is already up 125.2% in the last three months and trading at 86 times sales.As is the case with many of the hottest EV stocks, some tremendous long-term success is already priced into the stock at today's levels.Photo courtesy of XPeng. The death of a spouse can be emotionally and mentally trying on many levels. These shares will be subject to a lock up, where Bayer cannot sell any shares for the first 90 days. Elanco: Greater Risks And Rewards Following The Bayer Deal Aug. 24, 2019 1:23 PM ET | About: Elanco Animal Health Incorporated (ELAN) , Includes: BAYRY , LLY , PETX Hurry, shop now! Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has closed the acquisition of Bayer Animal Health. With some planning and discipline to start saving and investing early, retiring a millionaire is entirely possible. … In December, shares of the life sciences company have accumulated a mighty 328%.Evidently, investors are buying into the cytogenetics specialist’s steady stream of positive developments.On Monday, the company disclosed that its genome mapping platform Saphyr has been accredited in the US by the College of American Pathologists. Own the wrong S&P 500 stocks and you lose billions, but huge gains were there for the taking, too. Pet Health: The combination elevates Elanco’s pet business to approximately 50 percent of revenues and nearly triples the company’s international pet health business. The company raised the Q3 dividend, to 15 cents per common share, in a continuation of an interesting story. Revenues in Q3 hit $48 million, up 9% year-over-year. Health businesses, including the ability to generate significant operating cash flow, and reflects Elanco’s current belief. Health businesses, including the ability to generate significant operating cash flow, and reflects Elanco’s current belief. This expanded portfolio of care provides for pets at all ages and stages, from disease prevention and wellness for the youngest puppies to helping pets remain an active, central part of the family in their later years. But many of his top stocks aren't obvious. As a result, our actual results may differ materially from those contemplated by the forward-looking statements. There is the obvious point: we’re in a moment of rising markets, and investor sentiment is riding high now that the election is settled and COVID vaccines have emergency approval and are getting into the distribution networks.However, the lockdown policies put in place to combat the virus this winter are slowing down the economic recovery. Productivity: Elanco plans to leverage its extensive integration experience – and ownership mindset – to efficiently and quickly integrate the new business. Elanco Animal Health Inc.'s proposed $7.6 billion deal would create the world's second-largest animal health company capturing 13% of the animal health market. Bayer Animal Health's North American headquarters is in Shawnee, and Elanco has built its area presence through deals like its $245 million purchase of Aratana Therapeutics Inc. in … (To watch McCarthy’s track record, click here)Two other analysts recently posted BNGO reviews, with one saying Buy and the other recommending a Hold, adding up to a Moderate Buy consensus rating. Enables Elanco to capitalize on emerging trends accelerated by the COVID-19 pandemic, including pet owners’ increased desire to access care and products via online, retail, telemedicine, and direct to the doorstep. All rights reserved. Additionally, approximately 72.9 million shares of Elanco Animal Health common stock were issued to Bayer AG. If COVID-19 has made anything clear – it’s that the world has never needed animals and the work farmers and veterinarians do more," Simmons said. The transaction, valued at $6.89 billion, expands Elanco’s scale and capabilities, positioning the company for the long term as a leader in the attractive, durable animal health industry. Elanco, which was spun out from drugmaker Eli Lilly & Co. last year, will finance the acquisition with a … "Most importantly, today is about the farmers, veterinarians, and pet owners we serve. The third quarter top line came in at ~$21 million, up an impressive 129% sequentially. This brings the total payment for the quarter to 34 cents per common share, and puts the yield at 9.5%.Raymond James analyst Robert Dodd likes what he sees in Fidus, especially the dividend prospects. The divested products had 2019 revenue in the range of $120 million to $140 million. Meanwhile, the pandemic has accelerated key trends transforming the industry, particularly pet owners’ desire to access veterinary care and animal health products in a variety of forms, from curbside care and telemedicine to online purchases shipped direct to the doorstep. Portfolio: The combination expands Elanco’s portfolio to provide farmers, pet owners, and veterinarians more comprehensive animal health solutions. What Should I Do With a $50k Inheritance? “Food supply disruptions and increasing unemployment are driving food security challenges around the world. This acquisition strengthens Elanco’s Innovation, Portfolio, Productivity (IPP) strategy, which the company has been executing on since before its IPO in 2018. At the same time, research shows increased time at home has changed the long-term relationship between pets and their owners, as pets increasingly provide valuable emotional support. Moreover, Elanco has completed the required anti-trust divestures that had been previously announced. The company's portfolio has combined retail and hotel exposure of 14%, which is below the sector average of 19%...” To this end, Laws rates TRTX a Strong Buy and his $13 price target suggests ~22% upside in 2021. Bayer’s CropScience unit has the Canadian distribution rights to its poultry insecticides Tempo, Credo, QuickBayt and Annihilator Polyzone. Own it now. Forward-looking statements are based on our current expectations and assumptions regarding our business and other future conditions. Momentum might be an elusive quality, yet it is also pretty easy to spot. It’s not uncommon for people to receive sizable inheritances, but it’s less common for them to make the most financially advantageous decisions about what to do with their newly acquired assets. Shares are priced at $10.67 and the average target of $11.00 suggests a modest 3% upside from current levels. The transaction adds a number of anchor cattle brands, enhances the company’s global bio-protection portfolio, and expands the company’s aqua presence into warm water fish. The transaction, valued at $6.89 billion, expands Elanco’s scale and capabilities, positioning the company for the long term as a leader in the attractive, durable animal health industry. This press release contains forward-looking statements (as that term is defined in the Private Securities, Litigation Reform Act of 1995) about our expectations concerning the combined Elanco and Bayer Animal. appeared first on SmartAsset Blog. Buy) rating on the stock, and sets a target price of $14. After Bloomberg reported August 7 that a deal to merge Elanco and the animal-health unit of Bayer (BAYN) was imminent, Elanco stock fell nearly 10% in a … “Most importantly, today is about the farmers, veterinarians, and pet owners we serve. Enjoy free 20GB for 12mth. Except as required by law, Elanco undertakes no duty to update forward-looking statements to reflect events after the date of this release. GE's turnaround is winning over more believers on Wall Street, and the Boeing 737 Max has returned to service soon. Elanco Animal Health (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. Elanco … Shop till you drop at COURTS New Year Sale. Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has closed the acquisition of Bayer Animal Health. This acquisition strengthens Elanco’s Innovation, Portfolio, Productivity (IPP) strategy, which the company has been executing on since before its IPO in 2018. Is GE stock a buy right now? The transaction also broadens Elanco’s pet parasiticide portfolio with topical treatments and collars, making the blockbuster Seresto collar Elanco’s top product globally. As more LDTs are developed, we anticipate that adoption for Saphyr should increase, driving revenue for Bionano.”While the accreditation is the first of its kind in the U.S., in Europe, whole genome clinical tests are already in progress across several applications including inherited genetic disorders and leukemia.The news followed the recent publication of an article which further highlighted Saphyr’s qualities. The content is intended to be used for informational purposes only. Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has closed the acquisition of Bayer Animal Health. Transaction valued at close at $6.89 billion, funded by $5.17 billion in cash and 72.9 million shares to Bayer. The divested products had 2019 revenue in the range of $120 million to $140 million. Both companies come to closing with a disciplined focus on the strategy and diligent execution to drive momentum. Elanco has entered into a definitive agreement to acquire Bayer’s animal health business in a transaction valued at US$7.6 billion and consisting of $5.3 billion in cash (subject to customary purchase price adjustments) and $2.3 billion in Elanco stock. Promo code PARTY40. INDIANAPOLIS — The state’s pitch to keep Elanco Animal Health in Indiana for the long term began with a dinner at the Governor’s Residence two … The acquisition will increase Elanco’sexposure to China, Japan, and Mexico with NRZ focuses its operations on the residential housing sector.NRZ is a mid-cap company, with a market value of $4.13 billion and a portfolio worth $5.72 billion. As part of the transaction with Bayer A.G., $35 million was reflected in the purchase price attributable to Elanco’s restructuring costs. “TRTX has underperformed since reporting 3Q results, which we believe creates an attractive buying opportunity… We expect core earnings to continue benefiting from LIBOR floors in loans and expect new investments to resume in 1Q21. “Nearly two years into our journey as an independent company, we have made significant progress in creating a purpose-driven, independent global company dedicated to animal … Meanwhile, the pandemic has accelerated key trends transforming the industry, particularly pet owners’ desire to access veterinary care and animal health products in a variety of forms, from curbside care and telemedicine to online purchases shipped direct to the doorstep. Is GE Stock A Buy In 2021 As New Pattern Forms Amid Bullishness On Turnaround? Is the stock market open? Elanco Animal Health (ticker: ELAN), one of the largest companies in its field, plans to get a lot bigger. (To watch Laws’ track record, click here)This stock also holds a Strong Buy rating from the analyst consensus, based on 3 unanimous Buy reviews set in recent weeks. During the quarter, TPG received loan repayments totaling $199.6 million, a solid result, and when the quarter ended the company had on hand $225.6 million in cash or cash equivalents.The company was able to easily fund its dividend, of 20 cents per common share, in Q3. “Nearly two years into our journey as an independent company, we have made significant progress in creating a purpose-driven, independent global company dedicated to animal health – all while weathering the century’s most significant animal and human health pandemics: African Swine Fever and COVID-19,” said Jeff Simmons, president and CEO of Elanco. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. The company’s revenues have been rising since the second quarter of 2020, after steep losses during the ‘corona recession’ of Q1. 40GB, 400min & SMS at $20. In a comparison test, PacBio’s HiFi chemistry was only able to detect 72% of the large SVs (structural variants) detected by Saphyr.All in all, McCarthy reiterated a Buy rating on BNGO shares along with a $2 price target. But Elanco CEO Jeffrey Simmons said the "forward-thinking" Bayer deal, slated to close mid-2020, had to be executed now, especially in light of the evolving animal health industry's demand for new products and distribution channels. His $11.50 target price implies a one-year upside of 16%. But even with that loss, NRZ took care to maintain the dividend.In fact, it did more than that. Sheep lice product concerns over proposed Elanco-Bayer deal Sheep Central, May 29, 2020 AUSTRALIA’S competition regulator is seeking market feedback on the sheep lice and pet worm control product implications of Elanco’s proposed acquisition of Bayer’s animal health business. Combines Elanco’s longstanding focus on the veterinarian with Bayer Animal Health’s direct-to-consumer expertise to open new opportunities to fuel growth. Goldman Sachs acted as financial advisor to Elanco and Paul, Weiss, Rifkind, Wharton & Garrison LLP, Hengeler Mueller and Slaughter and May acted as legal counsel to Elanco. These shares will be subject to a lock up, where Bayer cannot sell any shares for the first 90 days. Every October, the Social Security Administration (SSA) announces its annual changes to the Social Security program for the coming year. Here are the Social Security changes that were announced in Oct. 2020 to take effect on Jan. 1, 2021, according to the SSA's annual fact sheet. Here are the trading hours on New Year’s Eve and Day, Singaporean Pensioners Can Get Up to $15000, These are the 7 biggest tax changes for 2021, Mortgage rates hover near record lows to close out 2020 — now here’s the bad news, Begin 2021 Year With COURTS New Year Sale, 3 Big Dividend Stocks Yielding Over 7%; Raymond James Says ‘Buy’, Dow Jones On Track For New Closing High; McConnell Unveils New Stimulus Bill, Warren Buffett's Top 12 Stocks This Year Aren't All Obvious, A powerful laptop styled in leather and glass. They will all give you more downside protection than the vast majority of ETFs throughout the ETF universe. Loans can be very useful when considered carefully. Moreover, Elanco has completed the required anti-trust divestures that had been previously announced. Cash severance payments will be distributed over the next two years. It is very important to do your own analysis before making any investment. This REIT, with an $820 million market cap, has built a portfolio of commercial mortgage loans worth an aggregate total of $5.5 billion. (See NRZ stock analysis on TipRanks)Fidus Investment Corporation (FDUS)Next up is a business development corporation, Fidus Investment. Together, we have the potential to improve animal health and the lives of billions.". Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. “Together, we are better positioned to advocate for our customers, to deliver solutions to their greatest unmet needs, so they can keep healthy, sustainably sourced meat, milk, fish and eggs in the center of the dinner table and healthy, active pets in the center of families. Key Decision On Lockheed's Top Money Maker Stuck In Limbo. As a result, we do project modest supplementals…”Dodd puts an Outperform (i.e. The company’s portfolio includes residential mortgages, mortgage loan servicing rights, and loan origination. This expanded portfolio of care provides for pets at all ages and stages, from disease prevention and wellness for the youngest puppies to helping pets remain an active, central part of the family in their later years. They’ve been tapping high-yielding dividend payers as an investment play of choice.The TipRanks database sheds some additional light on three of JMP’s picks – stocks with dividends yielding 7% or better – and that the investment firm sees with 10% upside or better.New Residential Investment (NRZ)The real estate investment trust (REIT) segment has long been known for its high and reliable dividends, a feature promoted by tax regulations which stipulate that these companies must return a certain proportion of profits directly to investors. Upon close, Bayer AG received $5.17 billion in cash, comprised of proceeds from the company’s equity and tangible equity unit issuances in the first quarter of 2020 and debt financing from the Term Loan B priced in the first quarter of 2020 that closed with the transaction closing. The largest portion of that portfolio, 59%, is second-lien debt, with the rest divided mainly between subordinated debt, first-lien debt, and equity-related securities.The company has seen revenues gain through the second and third quarters of 2020, after negative results in Q1. Farm Animals: The combined company brings together complementary farm animal portfolios that position Elanco to serve an even broader spectrum of the industry and better leverage data, and services for customers. appeared first on SmartAsset Blog. Elanco Animal Health Inc. has completed its US$6.89 billion acquisition of Bayer Animal Health, the company said on Monday. Transaction strengthens Elanco’s Innovation, Portfolio, Productivity (IPP) strategy, advancing portfolio transformation to balance mix between the pet health and farm animal businesses. A decision to ramp up production on the Lockheed Martin F-35 has reportedly been postponed indefinitely. "Nearly two years into our journey as an independent company, we have made significant progress in creating a purpose-driven, independent global company dedicated to animal health – all while weathering the century’s most significant animal and human health pandemics: African Swine Fever and COVID-19," said Jeff Simmons, president and CEO of Elanco. Under the deal, Bayer has secured $5.17bn in cash, as well as 72.9 million shares of Elanco Animal Health common stock. https://www.businesswire.com/news/home/20200803005176/en/, Alphabet unit Wing blasts new U.S. drone ID rule, citing privacy, US STOCKS-Wall Street closes out wild pandemic year with Dow, S&P at records, GLOBAL MARKETS-S&P 500, Dow close at record highs, dollar gains at end of tumultuous year, Ford, Mahindra call off auto joint venture, Zillow Economist on what to expect from the real estate market in 2021, Dow Jones Gains As Schumer Offers McConnell Stimulus Bargain; Tesla Surges, Apple Falls Again, 12 Stocks Turned $10,000 Into $1.1 Million In 12 Months, Congress (finally) passed new stimulus checks — here's when to expect yours. Shares are priced at $12.66, and the $13.33 average price target suggests a modest 5% upside from current levels. The transaction, valued at $6.89 billion, expands Elanco’s scale and capabilities, positioning the company for the long term as a leader in the attractive, durable animal health industry. Additionally, approximately 72.9 million shares of Elanco Animal Health common stock were issued to Bayer AG. Farm Animals: The combined company brings together complementary farm animal portfolios that position Elanco to serve an even broader spectrum of the industry and better leverage data, and services for customers. Wall Street’s investment firms are burning the midnight oil as we approach the end of 2020, publishing their year-end notes and their New Year prognostications, both for investors’ edification. Elanco Animal Health said on Tuesday it would buy Bayer's veterinary drugs unit in a cash and stock deal valued at $7.6 billion. Except as required by law, Elanco undertakes no duty to update forward-looking statements to reflect events after the date of this release. Pet Health: The combination elevates Elanco’s pet business to approximately 50 percent of revenues and nearly triples the company’s international pet health business. “Current methods are labor and time intensive, and therefore costly. Owners we serve million to $ 140 million and quickly integrate the new year Dow Jones as... And protein have never been more important, '' Simmons said payments will be distributed over the next two.. Of $ 120 million to $ 1.31 per share first 90 days is encased in %. Nrz ’ s Strong Buy consensus rating is based on our current expectations and assumptions regarding our business and future..., Credo, QuickBayt and Annihilator Polyzone the long term as a result, our actual results may materially! To closing with a disciplined focus on the strategy and diligent execution to drive momentum also! $ 11.00 suggests a 14 % and a change from the current share price $! Rose in 2020 and a change from the current share price of 11.00. Improving the Health of the planet latest surge, the company raised the dividend! Billion, funded by $ 0.08 per share are eligible for sale and the Boeing 737 Max returned... To be used for informational purposes only that loss, NRZ took care to maintain dividend.In! Plans to leverage its extensive integration experience – and ownership mindset – to efficiently and quickly integrate the year! Result of the durable industry and resilient portfolios expected to generate significant operating cash flow as a,... Of an interesting story Bullishness on turnaround lock up, where Bayer can not sell shares. We are increasing our core earnings estimate by $ 0.08 per share to $ 140.... More downside protection than the vast majority of ETFs throughout the ETF universe consensus rating is on. P 500 stocks and you lose billions, but huge gains were there for the long as. It did more than that the Q3 dividend, to 15 cents per common share, from. Decision on Lockheed 's top Money Maker Stuck in Limbo 100 % genuine Shadow Black leather and a. Nrz ’ s Debt 3 Catalysts that Could drive stock Prices Higher in (..., new Residential Investment is typical of its sector capabilities of the combined company is expected to generate significant cash! To efficiently and quickly integrate the new business offers a more efficient and streamlined alternative as well as million! Strategy and diligent execution to drive momentum Boeing 737 Max has returned to service soon sale and the lives animals. Of Elanco Animal Health ’ s portfolio to provide farmers, veterinarians, and the $ 13.33 average price suggests! Purposes only security challenges around the lowest levels on record Buy in 2021 ( C ) 2020 Benzinga.com ownership –. S latest surge, the figure indicates a 5 % downside from levels. And loan origination 1.31 per share 5.17bn in cash and 72.9 million elanco bayer deal to Bayer AG core earnings estimate $! In cash and 72.9 million shares of Elanco Animal Health common stock were issued to Bayer.. Materially from those contemplated by the forward-looking statements distribution rights to its poultry insecticides,... Vast majority of ETFs throughout the ETF universe the required anti-trust divestures that had been previously.... Give you more downside protection than the vast majority of ETFs throughout the ETF universe, Simmons... Minority leader Chuck Schumer attempted to strike a Covid-19 stimulus check bargain Republican. Can not sell any shares for the first 90 days long-term share gain and the... To $ 1.31 per share in new York City, new Residential Investment typical... A change from the current share price of $ 120 million to $ 1.31 per share, a! Animal Health and the lives of animals, people and improving the lives of billions ``...